Locations:
Search IconSearch

Neurosciences

19-NEU-463-epilepsy-650×450

Integrated Studies Focus in on Optimal Prediction of Epilepsy Treatment Response

Grant enables pooling of genomics, molecular medicine, animal models, advanced neuroimaging

19-NEU-3855-Exoskeleton-650×450
July 31, 2019/Neurosciences/Research

Piloting a Powered Exoskeleton for Gait Training in Multiple Sclerosis

New study aims to assess a potential new indication for the technology

18-NEU-514-Parkinsons-brain-650×450
July 25, 2019/Neurosciences/Education

Keeping Pace With Parkinson Disease Developments

Special issue of the IAPRD’s journal delivers updates on a fast-evolving field

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-4042-social-buzz-650×450

Can Social Media Buzz Increase Your Academic Citations?

Study looks for correlations in neurology research

19-NEU-318 T-cell-activation-650×450

Grant Boosts Efforts to Take on Glioblastoma by Targeting Immunosuppressive Cells

Focus is on inhibiting action of myeloid-derived suppressor cells

16-NEU-1936-Alberts-650×450

Concussion App Identifies Red Flag Symptoms and Streamlines Injury Reporting

App aids clinical management and documentation of sport-related concussion injuries

Self-portrait
July 15, 2019/Neurosciences/Research

Tardive Dyskinesia Therapy Holds Up Over Long-Term Assessment

Extension study of VMAT2 inhibitor helps confirm a new therapeutic era

AMI-Tuck-1642295     06-25-19

Therapeutic Arts Program Aims to Make Patients Resilient in the Face of Multiple Sclerosis

Early results with ‘HeRe We Arts’ spur testing in a randomized trial

BackPage 60 of 107Next

Advertisement

Ad